Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.36 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.36 |
| ▸ | P2RY12 | Q9H244 | 3/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 10/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9191955 | 0.88 | HCAR2 (0.45) | MEN1TSHRKMT2APDE3BPDE3A | |
| SCHEMBL3817859 | 0.75 | TNKS2 (0.44) | HCAR2L3MBTL1 | |
| SCHEMBL9194026 | 0.69 | HCAR2 (0.44) | HCAR2GAA | |
| SCHEMBL9190090 | 0.69 | KDM4E (0.40) | MEN1TSHRKMT2AKDM4EGAA | |
| SCHEMBL29123832 | 0.67 | KDM4E (0.68) | MEN1TSHRKMT2AKDM4EGAA | |
| SCHEMBL9191397 | 0.67 | ALDH1A1 (0.39) | TSHRHCAR2HTTKDM4EGAA | |
| SCHEMBL9287657 | 0.65 | HCAR2 (0.47) | HCAR2HTTL3MBTL1 | |
| SCHEMBL9189988 | 0.65 | HCAR2 (0.56) | TSHRHCAR2 | |
| Acetic Acid SCHEMBL29043334 | 0.65 | GAA (0.47) | KDM4EGAA | |
| SCHEMBL7078925 | 0.65 | MAPT (0.63) | HTTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5167949-A | Antiallergic | LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1992-12-01 | — | — | US | disclosed |